Senior Consultant
SingHealth Duke-NUS Blood Cancer Centre
Senior Consultant
Haematology Oncology Service
Senior Consultant
Paediatric Brain and Solid Tumour Programme
Clinical Asst Professor
Dr Michaela Seng is a Senior Consultant in the Department of Paediatric Haematology and Oncology, subspecialising in Blood and Marrow Transplants and Cellular Therapies (BMTCT), with clinical expertise in high-risk childhood blood cancers, cellular therapies and haematopoietic stem cell transplants for relapsed/refractory malignant and life-limiting non-malignant diseases. Dr Seng completed a PhD in the field of translational cellular therapies under the NMRC Research Training Fellowship. She is a committed clinician scientist supported by NMRC Talent Development awards and is nationally funded for her research. Her research interest is in translational cell therapies for relapsed/refractory childhood cancers, motivated by the treatment failures in her practice.
Contributions: Dr Seng led the KKH BMTCT programme to FACT accreditation for transplant and immune effector cell therapies in 2026. She established the early frameworks of the Paediatric Oncology Survivorship Programme in Singapore and the Paediatric Transplant and Cell Therapy Registry during her junior faculty years. She is the Principal Investigator of a translational research laboratory in the Children’s Blood and Cancer Centre and is actively involved in investigator-initiated clinical trials for novel cellular therapies.
Current Appointments: Dr. Michaela Seng holds leadership and committee appointments within the hospital, SingHealth cluster and MOH, as listed below. She holds faculty and mentor roles at the Duke-NUS Medical school and Lee Kong Chian Medical School. She volunteers as a medical sub-committee board member of the Bone Marrow Donor Programme.
Investigator-Initiated Clinical Trials
Leukaemia Consortium Studies
Solid Tumour Consortium Studies
Registry/ Tissue Studies